Giordano Christopher Thomasinsider trades

In SEC Form 4 filings, Giordano Christopher Thomas is listed as CEO of Tenax Therapeutics, Inc. (TENX). In the last 90 days, Giordano Christopher Thomas bought $20.1K of Tenax Therapeutics, Inc. (TENX) on the open market and sold none. The largest purchase was $11.3K of Tenax Therapeutics, Inc. (TENX) on Sep 11. Took part in a cluster buy; the latest at Tenax Therapeutics, Inc. (TENX), where 4 insiders bought within 14 days, ending Sep 16.

Companies and roles

Company	Role	Transactions	Last filed
TENXTenax Therapeutics, Inc.	CEO	2	Sep 15

Cluster buys

TENX: 4 insiders bought $1.74M between Sep 3 – Sep 16.

Form 4 historysince 2026-09-15

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
TENXTenax Therapeutics, Inc.	Sep 15	Sep 15	P	4,850	$1.82	Purchase +$8,837	22,174	No	Form 4
TENXTenax Therapeutics, Inc.	Sep 11	Sep 15	P	6,000	$1.88	Purchase +$11,250	17,324	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.